Clinical trial
Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury…
NCT00321802 · University of Calgary, Other · Completed
Key facts
| NCT number | NCT00321802 |
|---|---|
| Title | Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins |
| Official title | Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins |
| Acronym | PAFRIOSIES |
| Lead sponsor | University of Calgary, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry Canadian Institutes of Health Research (CIHR) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Simvastatin, Placebo |
| Enrollment | 40 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | May 4, 2006 |
| Last update posted | Jan 1, 2015 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: